Beaconlight Capital’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-125,403
Closed -$4.44M 39
2020
Q2
$4.44M Sell
125,403
-12,929
-9% -$368K 1.48% 24
2020
Q1
$3.02M Buy
138,332
+62,316
+82% +$1.4M 0.8% 26
2019
Q4
$1.64M Buy
76,016
+53,716
+241% +$1.23M 0.35% 30
2019
Q3
$504K Buy
+22,300
New +$618K 0.13% 37
2018
Q4
Sell
-258,276
Closed -$7.45M 29
2018
Q3
$7.45M Buy
+258,276
New +$4.83M 2.43% 16

Other funds holding CDNA

Beaconlight Capital's CDNA Position: Q3 2020 in Review

Beaconlight Capital sold out of CareDx (CDNA) in Q3 2020, closing a stake of 125,403 shares — an estimated $4.44M sold.

Beaconlight Capital first reported a position in CDNA in Q3 2018 and held it in 5 quarters. The position peaked at $7.45M in Q3 2018. 197 funds tracked by Wall St. Rank hold CDNA as of Q3 2020.

  • Beaconlight Capital reported no remaining CareDx position as of Q3 2020 after selling out during the quarter.
  • Beaconlight Capital sold 125,403 CareDx shares in Q3 2020, an estimated $4.44M.
  • Beaconlight Capital first reported a position in CareDx in Q3 2018 and held it in 5 quarters.
  • Beaconlight Capital's CareDx position peaked at $7.45M in Q3 2018.
  • 197 funds tracked by Wall St. Rank held CareDx as of Q3 2020.

Based on Beaconlight Capital's 13F filing for Q3 2020, filed 16 Nov 2020.